HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of type VI collagen in experimental and most spontaneous human fibrosarcomas.

Abstract
Expression of type VI collagen, an adhesive protein of mesenchymal tissues, is significantly down-regulated upon viral transformation of fibroblasts. Likewise, most cell lines derived from spontaneous mesenchymal tumors, including fibrosarcomas, rhabdomyosarcomas, leiomyosarcomas, chondrosarcomas and liposarcomas, do not synthesize type VI collagen because they are not capable of expressing all 3 of the polypeptide chains required for the assembly of a functional heterotrimeric molecule. When injected into nude mice, neither fibrosarcoma cells (HT1080) nor rhabdomyosarcoma cells (A204) initiate the synthesis of type VI collagen, suggesting that the inhibition is not caused by deficiency of a paracrine factor. Immuno-histochemical studies further illustrate that 15 of 17 spontaneous adult fibrosarcomas lack type VI collagen in the tumor stroma. The absence of this important adhesion protein may contribute to tumorigenicity, invasiveness and/or metastasis of mesenchymal tumor cells.
AuthorsB Trueb, B F Odermatt
JournalInternational journal of cancer (Int J Cancer) Vol. 86 Issue 3 Pg. 331-6 (May 01 2000) ISSN: 0020-7136 [Print] United States
PMID10760819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2000 Wiley-Liss, Inc.
Chemical References
  • Collagen
Topics
  • Adult
  • Animals
  • Collagen (biosynthesis, genetics)
  • Fibrosarcoma (genetics, metabolism, pathology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness (genetics)
  • Neoplasm Transplantation
  • Rhabdomyosarcoma (genetics, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: